{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T10:25:04Z","timestamp":1786443904336,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T00:00:00Z","timestamp":1561593600000},"content-version":"am","delay-in-days":361,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Alkermes Biopharmaceticals"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Forest\/Actavis"},{"name":"Ortho-McNeil-Janssen Pharmaceuticals, Inc."},{"DOI":"10.13039\/100004319","name":"Pfizer, Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009655","name":"Sunovion Pharmaceuticals, Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["5T32HD052458"],"award-info":[{"award-number":["5T32HD052458"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.genhosppsych.2018.05.010","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T12:44:11Z","timestamp":1527597851000},"page":"73-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Obstetrical and neonatal outcomes after benzodiazepine exposure during pregnancy: Results from a prospective registry of women with psychiatric disorders"],"prefix":"10.1016","volume":"53","author":[{"given":"Marlene P.","family":"Freeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"G\u00f3ez-Mogoll\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"McInerney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail C.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor R.","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra Z.","family":"Sosinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia B.","family":"Noe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele C.","family":"Viguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee S.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.genhosppsych.2018.05.010_bb0005","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.genhosppsych.2018.05.010_bb0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.31887\/DCNS.2015.17.3\/bbandelow","article-title":"Epidemiology of anxiety disorders in the 21st century","volume":"17","author":"Bandelow","year":"2015","journal-title":"Dialogues Clin Neurosci"},{"issue":"10","key":"10.1016\/j.genhosppsych.2018.05.010_bb0015","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.4088\/JCP.v69n1011","article-title":"Gender differences in generalized anxiety disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)","volume":"69","author":"Vesga-Lopez","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"10.1016\/j.genhosppsych.2018.05.010_bb0020","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jpsychires.2011.03.006","article-title":"Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness","volume":"45","author":"Mclean","year":"2011","journal-title":"J Psychiatr Res"},{"issue":"1\u20133","key":"10.1016\/j.genhosppsych.2018.05.010_bb0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jad.2011.01.003","article-title":"Generalized anxiety disorder: course and risk factors in pregnancy","volume":"131","author":"Buist","year":"2011","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.genhosppsych.2018.05.010_bb0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jad.2003.08.004","article-title":"The course of anxiety and depression through pregnancy and the postpartum in a community sample","volume":"80","author":"Heron","year":"2004","journal-title":"J Affect Disord"},{"issue":"8","key":"10.1016\/j.genhosppsych.2018.05.010_bb0035","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.4088\/JCP.v67n0818","article-title":"Anxiety disorders during pregnancy and the postpartum period: a systematic review","volume":"67","author":"Ross","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.genhosppsych.2018.05.010_bb0040","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jad.2009.07.002","article-title":"Panic disorder as a risk factor for post-partum depression: results from the perinatal depression-research & screening unit (PND-ReScU) study","volume":"122","author":"Rambelli","year":"2010","journal-title":"J Affect Disord"},{"issue":"6","key":"10.1016\/j.genhosppsych.2018.05.010_bb0045","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.comppsych.2007.06.004","article-title":"Panic disorder, trait anxiety, and alcohol use in pregnant and nonpregnant women","volume":"48","author":"Meshberg-Cohen","year":"2007","journal-title":"Compr Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2018.05.010_bb0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1740-8709.2010.00257.x","article-title":"Impact of mothers' negative affectivity, parental locus of control and child-feeding practices on dietary patterns of 3-year-old children: the MoBa Cohort Study","volume":"8","author":"Ystrom","year":"2012","journal-title":"Matern Child Nutr"},{"key":"10.1016\/j.genhosppsych.2018.05.010_bb0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jad.2014.02.027","article-title":"Maternal anxiety during pregnancy and adverse birth outcomes: a systematic review and meta-analysis of prospective cohort studies","volume":"159","author":"Ding","year":"2014","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2018.05.010_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.wombi.2016.03.004","article-title":"Effects of prenatal maternal mental distress on birth outcomes","author":"Liou","year":"2016","journal-title":"Women Birth"},{"issue":"13","key":"10.1016\/j.genhosppsych.2018.05.010_bb0065","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3109\/14767058.2013.858242","article-title":"Obstetric and neonatal outcome in patients with anxiety disorders","volume":"27","author":"Pavlov","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1\u20132","key":"10.1016\/j.genhosppsych.2018.05.010_bb0070","first-page":"25","article-title":"Risk of spontaneous preterm birth in relation to maternal depressive, anxiety, and stress symptoms","volume":"58","author":"Sanchez","year":"2013","journal-title":"J Reprod Med"},{"issue":"8","key":"10.1016\/j.genhosppsych.2018.05.010_bb0075","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.earlhumdev.2012.01.014","article-title":"Depression and anxiety in women during pregnancy and neonatal outcome: data from the EDEN mother-child cohort","volume":"88","author":"Ibanez","year":"2012","journal-title":"Early Hum Dev"},{"issue":"3","key":"10.1016\/j.genhosppsych.2018.05.010_bb0080","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00737-005-0090-z","article-title":"Neonatal outcomes in offspring of women with anxiety and depression during pregnancy. A linkage study from The Nord-Trondelag Health Study (HUNT) and Medical Birth Registry of Norway","volume":"8","author":"Berle","year":"2005","journal-title":"Arch Womens Ment Health"},{"issue":"4","key":"10.1016\/j.genhosppsych.2018.05.010_bb0085","first-page":"487","article-title":"Depression and anxiety in early pregnancy and risk for preeclampsia","volume":"95","author":"Kurki","year":"2000","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.genhosppsych.2018.05.010_bb0090","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/aje\/kwh122","article-title":"Neonatal outcome following maternal antenatal depression and anxiety: a population-based study","volume":"159","author":"Andersson","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.genhosppsych.2018.05.010_bb0095","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.earlhumdev.2010.04.004","article-title":"Anxiety disorders before birth and self-perceived distress during pregnancy: associations with maternal depression and obstetric, neonatal and early childhood outcomes","volume":"86","author":"Martini","year":"2010","journal-title":"Early Hum Dev"},{"issue":"3","key":"10.1016\/j.genhosppsych.2018.05.010_bb0100","doi-asserted-by":"crossref","DOI":"10.17795\/nmsjournal29308","article-title":"Limited depressive and anxiety symptoms late in pregnancy are not related to neonatal outcomes","volume":"4","author":"Varela","year":"2015","journal-title":"Nurs Midwifery Stud"},{"issue":"11","key":"10.1016\/j.genhosppsych.2018.05.010_bb0105","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jamapsychiatry.2017.2733","article-title":"Association of panic disorder, generalized anxiety disorder, and benzodiazepine treatment during pregnancy with risk of adverse birth outcomes","volume":"74","author":"Yonkers","year":"2017","journal-title":"JAMA Psychiat"},{"key":"10.1016\/j.genhosppsych.2018.05.010_bb0110","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1471-2393-14-242","article-title":"Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance","volume":"14","author":"Hanley","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"issue":"7162","key":"10.1016\/j.genhosppsych.2018.05.010_bb0115","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/bmj.317.7162.839","article-title":"Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies","volume":"317","author":"Dolovich","year":"1998","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.genhosppsych.2018.05.010_bb0120","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1176\/ajp.153.5.592","article-title":"Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines","volume":"153","author":"Altshuler","year":"1996","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.genhosppsych.2018.05.010_bb0125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0890-6238(94)90029-9","article-title":"The effects of benzodiazepine use during pregnancy and lactation","volume":"8","author":"Mcelhatton","year":"1994","journal-title":"Reprod Toxicol"},{"issue":"8031","key":"10.1016\/j.genhosppsych.2018.05.010_bb0130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(77)92855-0","article-title":"\"Floppy infant syndrome\" and maternal diazepam","volume":"2","author":"Gillberg","year":"1977","journal-title":"Lancet"},{"issue":"3 Suppl","key":"10.1016\/j.genhosppsych.2018.05.010_bb0135","first-page":"34s","article-title":"Neonatal apnea associated with maternal clonazepam therapy: a case report","volume":"66","author":"Fisher","year":"1985","journal-title":"Obstet Gynecol"},{"issue":"5887","key":"10.1016\/j.genhosppsych.2018.05.010_bb0140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/bmj.4.5887.251","article-title":"Diazepam in labour: its metabolism and effect on the clinical condition and thermogenesis of the newborn","volume":"4","author":"Cree","year":"1973","journal-title":"Br Med J"},{"issue":"5","key":"10.1016\/j.genhosppsych.2018.05.010_bb0145","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/JCP.0b013e3182668568","article-title":"Neonatal complications after maternal concomitant use of SSRI and other central nervous system active drugs during the second or third trimester of pregnancy","volume":"32","author":"Kallen","year":"2012","journal-title":"J Clin Psychopharmacol"},{"issue":"10","key":"10.1016\/j.genhosppsych.2018.05.010_bb0150","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/ph6101221","article-title":"The use of central nervous system active drugs during pregnancy","volume":"6","author":"Kallen","year":"2013","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.genhosppsych.2018.05.010_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.06.061","article-title":"Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy","volume":"201","author":"Calderon-Margalit","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.genhosppsych.2018.05.010_bb0160","doi-asserted-by":"crossref","first-page":"986","DOI":"10.4088\/JCP.14br09418","article-title":"Establishment of the National Pregnancy Registry for atypical antipsychotics","volume":"76","author":"Cohen","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2018.05.010_bb0165","author":"Centers for Disease Control and Prevention NCfHS"},{"key":"10.1016\/j.genhosppsych.2018.05.010_bb0170","series-title":"FDA Drug Safety Communication: Antipsychotic Drug Labels Updated on Use During Pregnancy and Risk of Abnormal Muscle Movements and Withdrawal Symptoms in Newborns","author":"Administration UFaD","year":"2011"},{"issue":"6","key":"10.1016\/j.genhosppsych.2018.05.010_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.06.061","article-title":"Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy","volume":"201","author":"Calderon-Margalit","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2018.05.010_bb0180","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-2008-1071305","article-title":"The effect of benzodiazepines on the fetus and the newborn","volume":"23","author":"Laegreid","year":"1992","journal-title":"Neuropediatrics"},{"issue":"2","key":"10.1016\/j.genhosppsych.2018.05.010_bb0185","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-2008-1071314","article-title":"Neurodevelopment in late infancy after prenatal exposure to benzodiazepines\u2013a prospective study","volume":"23","author":"Laegreid","year":"1992","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.genhosppsych.2018.05.010_bb0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2147\/DHPS.S50556","article-title":"Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges","volume":"7","author":"Epstein","year":"2014","journal-title":"Drug Healthc Patient Saf"},{"key":"10.1016\/j.genhosppsych.2018.05.010_bb0195","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-clinpsy-032813-153626","article-title":"Antidepressant use in pregnant and postpartum women","volume":"10","author":"Yonkers","year":"2014","journal-title":"Annu Rev Clin Psychol"},{"key":"10.1016\/j.genhosppsych.2018.05.010_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/ana.25215","article-title":"Fetal growth and premature delivery in pregnant women on anti-epileptic drugs","author":"Hern\u00e1ndez\u2010D\u00edaz","year":"2018","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.genhosppsych.2018.05.010_bb0205","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/ph6101221","article-title":"The use of central nervous system active drugs during pregnancy","volume":"6","author":"K\u00e4ll\u00e9n","year":"2013","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.genhosppsych.2018.05.010_bb0210","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1037\/a0035491","article-title":"Effect of cognitive behavioral therapy for anxiety disorders on quality of life: a meta-analysis","volume":"82","author":"Hofmann","year":"2014","journal-title":"J Consult Clin Psychol"},{"issue":"7177","key":"10.1016\/j.genhosppsych.2018.05.010_bb0215","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/bmj.318.7177.153","article-title":"Association between maternal anxiety in pregnancy and increased uterine artery resistance index: cohort based study","volume":"318","author":"Teixeira","year":"1999","journal-title":"BMJ"},{"issue":"3\u20134","key":"10.1016\/j.genhosppsych.2018.05.010_bb0220","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1469-7610.2006.01714.x","article-title":"Antenatal maternal stress and long-term effects on child neurodevelopment: how and why?","volume":"48","author":"Talge","year":"2007","journal-title":"J Child Psychol Psychiatry"},{"issue":"4","key":"10.1016\/j.genhosppsych.2018.05.010_bb0225","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/0167482X.2014.952279","article-title":"Moderate antenatal anxiety symptoms and birth outcomes of boys and girls","volume":"35","author":"Kaitz","year":"2014","journal-title":"J Psychosom Obstet Gynaecol"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834317304942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834317304942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:49:59Z","timestamp":1759013399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834317304942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":45,"alternative-id":["S0163834317304942"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2018.05.010","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obstetrical and neonatal outcomes after benzodiazepine exposure during pregnancy: Results from a prospective registry of women with psychiatric disorders","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2018.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}